30 completed, 7 unknown, 4 not yet recruiting, 4 recruiting. 48 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 48 | Completed 30, Unknown 7, Not yet recruiting 4, Recruiting 4, Terminated 3 |
| Phase 2 | 7 | Completed 4, Unknown 2, Terminated 1 |
Follow Ceftriaxone: new trials by email Literature Review of Ceftriaxone trials Research Report on Ceftriaxone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis Piperacillin/Tazobactam, Ceftriaxone + Metronidazole - Appendicitis Perforated, Appendectomy, Laparoscopic | Phase 3 | Not yet recruiting | McMaster Children's Hospital | 180 | 2027-04-01 | 2026-10-09 |
| AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth Vaginal flora abnormalities screening and quantification using molecular biology technique, Azithromycin, Ceftriaxone - Bacterial Vaginosis, Vaginal Dysbiosis | Phase 3 | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 1794 | 2026-10-01 | 2026-08-27 |
| Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae Infections Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml), Rectal swab for ESBL-E and microbiota (Eswab), Temocillin (NEGABAN®) 2 g intramuscular single dose with lidocaine (3ml) - Neisseria Gonorrhoeae (Ng) Infections | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 360 | 2026-09-01 | 2026-06-22 |
| A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor Combination of antibiotics, Emergency cerclage, Vaginal progesterone - Previable Labour With Intact Membranes | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 350 | 2026-09-01 | 2026-05-01 |
| 500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection ceftriaxone 500-mg, ceftriaxone 1000-mg - Gonorrhea Infection | Phase 3 | Recruiting | National Taiwan University Hospital | 400 | 2026-07-01 | 2026-07-17 |
| PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury Ceftriaxone 2g diluted in >200ml 0.9%sodium chloride, Placebo comparator - no ceftriaxone - All-cause Mortality, Quality of Life | Phase 3 | Recruiting | The George Institute | 3300 | 2025-10-30 | 2026-08-28 |
| Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients ROCEPHIN, metronidazole, RIFADIN, IZILOX, placebo combination therapy, Lymecyclin and corresponding placebos of the experimental arm - Hidradenitis Suppurativa | Phase 3 | Recruiting | Institut Pasteur | 92 | 2025-05-22 | 2025-07-09 |
| Prophylactic Antibiotic in Subtalar Fusion Surgery Ceftriaxone 2000 mg - Surgical Site Infection | Phase 2 / Phase 3 | Unknown | Assiut University | 102 | 2024-09-01 | 2024-07-30 |
| Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria Ceftriaxone (Rocephin®), Levofloxacin - Urinary Tract Infection (Diagnosis) | Phase 2 / Phase 3 | Completed | Ain Shams University | 140 | 2024-07-01 | 2025-11-17 |
| Clearance of Asymptomatic Pharyngeal Carriage of Neisseria Gonorrhoeae With or Without Ceftriaxone Treatment: Randomized Non-inferiority Study Absence of antibiotic treatment, Ceftriaxone - Neisseria Gonorrhoeae Infection, Asymptomatic Pharyngeal Carriage | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 254 | 2023-09-01 | 2023-08-02 |
| Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma Ceftriaxone Sodium - Antibiotic Prophylaxis | Phase 3 | Unknown | Nadeem Iqbal | 158 | 2022-11-26 | 2022-12-16 |
| Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition Ceftriaxone Sodium, Ampicillin, Gentamicin - HIV-1-infection, Malnutrition, Child | Phase 2 / Phase 3 | Unknown | Makerere University | 300 | 2021-06-14 | 2021-09-30 |
| Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients Kunamin®, Favipiravir, Enoxaparin - COVID-19 Respiratory Infection, FLU | Phase 3 | Completed | RAAS Nutritionals, LLC | 71 | 2021-05-29 | 2022-06-14 |
| Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute | Phase 2 / Phase 3 | Completed | Haiphong University of Medicine and Pharmacy | 170 | 2020-01-01 | 2021-05-10 |
| Zoliflodacin in Uncomplicated Gonorrhoea zoliflodacin, ceftriaxone, azithromycin - Gonorrhea | Phase 3 | Completed | Global Antibiotics Research and Development Partnership | 1011 | 2019-11-06 | 2025-10-08 |
| A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Gepotidacin, Ceftriaxone, Azithromycin - Gonorrhea | Phase 3 | Completed | GlaxoSmithKline | 628 | 2019-10-21 | 2024-05-30 |
| A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia Benzyl penicillin, Gentamicin Sulfate, Ceftriaxone - Pneumonia | Phase 3 | Completed | University of Oxford | 4392 | 2019-08-19 | 2024-07-08 |
| New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea Ertapenem 1000 MG, Fosfomycin Oral Suspension, Gentamicin Sulfate, Injectable - Gonorrhea | Phase 3 | Completed | Public Health Service of Amsterdam | 346 | 2017-09-18 | 2021-08-06 |
| First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition Ceftriaxone, Benzyl penicillin, Metronidazole - Malnutrition Severe, Antibiotic Resistance | Phase 3 | Unknown | University of Oxford | 2000 | 2017-09-04 | 2020-05-19 |
| Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients SDD Oral Paste, SDD Gastric Suspension, Intravenous Antibiotic - Critical Illness, Sepsis | Phase 3 | Completed | The George Institute | 20010 | 2017-05-01 | 2023-08-14 |
Showing 20 of 48. Sign in to see all of them.
Gonorrhea (8) · Community-Acquired Pneumonia (7) · Pneumonia (7) · Infections (4) · Bacterial Infections (3) · Pneumonia, Bacterial (3) · Sepsis (3) · Urinary Tract Infections (3) · Disease (2) · Haemophilus Infections (2) · Influenza, Human (2) · Intraabdominal Infections (2) · Lyme Disease (2) · Premature Birth (2) · Sexually Transmitted Diseases (2)
Assistance Publique - Hôpitaux de Paris (6) · Bayer (3) · Forest Laboratories (3) · Melinta Therapeutics, Inc. (3) · Makerere University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Pfizer (2) · The George Institute (2) · University of Oxford (2) · Aga Khan University (1) · Ain Shams University (1) · Assistance Publique Hopitaux De Marseille (1) · Assiut University (1) · Basilea Pharmaceutica (1) · GlaxoSmithKline (1)
United States (12) · France (10) · Spain (6) · Australia (5) · Germany (5) · Hungary (5) · India (5) · United Kingdom (5) · Argentina (4) · Bulgaria (4) · Canada (4) · Netherlands (4) · Poland (4) · Belgium (3) · Mexico (3)
A.K. Deb (1) · Ahmad Zia Ud Din (1) · Ambrose Agweyu, PhD (1) · Andrew Udy, Prof (1) · Anita KM Zaidi, MBBS, SM (1) · Anthony Delaney, Prof (1) · Anthony Gordon, MD FRCA (1) · Antonella Toffolo, Dr (1) · Brian Cuthbertson, MD FRCA (1) · Colin McArthur, Dr (1) · Cordelia M Katureebe, MBCHB (1) · David Melnick (1) · Deepak Dewan (1) · Derek Angus, Prof (1)
PMID 26702925, PMID 30597021, PMID 34922058, PMID 21482570, PMID 23357290, PMID 25487791, PMID 17611232, PMID 18419482, PMID 18567539, PMID 18762516, PMID 21129208, PMID 21482566, PMID 21482568, PMID 22230331, PMID 23352693, PMID 23613806, PMID 24207137, PMID 25151205, PMID 25297012, PMID 25442806, PMID 25539586, PMID 25631195, PMID 26229155, PMID 27093162, PMID 28864675, PMID 30380060, PMID 30808293, PMID 30936104, PMID 30985632, PMID 31044546, PMID 31196813, PMID 31433059, PMID 32267771, PMID 32665381, PMID 32876697, PMID 33394942, PMID 33509275, PMID 33631065, PMID 33960817, PMID 34155899, PMID 34251506, PMID 34351721, PMID 34351722, PMID 34473343, PMID 34606578, PMID 35065063, PMID 35237053, PMID 35315874, PMID 35813373, PMID 35820778
2023 (3), 2014 (1), 2015 (1), 2018 (1), 2019 (1), 2025 (1), U01NS049640 (1)